Skip to content

Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma

Study for Elevate the Feasibility of Ovarian Preservation With Endometrial Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01560026
Acronym
ECWOP
Enrollment
300
Registered
2012-03-21
Start date
2000-08-31
Completion date
2012-12-31
Last updated
2012-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer

Keywords

ovarian preservation

Brief summary

Endometrial cancer is one of the most common female malignancies in the United States, and has increased in incidence in Taiwan in recent decades.A recent population-based analysis noted that 4% of endometrial cancers occurred in women aged 40 years or younger, furthermore it is up to 15% in Taiwan according to the data of cancer registry. The standard treatment of endometrial cancer results in surgical menopause and places patients at risk for the long-term sequelae of estrogen deprivation. The goal of this study was to determine the frequency of a coexisting ovarian malignancy and to evaluate the outcome of ovarian preservation in women with treatment for endometrial cancer.

Detailed description

we reviewed the cases with early stage of endometrial cancer who have primary staging surgery between January 1989 to December 2009. The enrolled patients will be divided into two group (oophorectomy vs. ovary preservation) for analysis:the outcome and recurrence type.To evaluate the outcome of ovarian preservation in women with endometrial cancer .

Interventions

PROCEDUREsurgery

endometrial cancer with or without oophorectomy

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* early stage endometrial cancer after primary surgery

Exclusion criteria

* MMMT, type 2 endometrial cancer

Design outcomes

Primary

MeasureTime frameDescription
from the time of diagnosis to the time of disease recurrence or last follow timedisease recurrence or last follow time, up to one yearthe time of diagnosis to the time of disease recurrence or last follow time

Countries

Taiwan

Contacts

Primary ContactYi-Jen Chen, MD
chenyj@vghtpe.gov.tw886-2-28757566

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026